Inmune Bio files warrant purchase agreement

Inmune Bio Inc. has filed a form of common stock purchase warrant with the SEC. The warrant grants the holder the right to purchase up to 20 million shares of common stock at an exercise price of $0.0157, with an initial exercise date of April 27, 2027. This non-dilutive financing mechanism is a standard practice for advancing cash-rich early-stage companies.